| PDF (754kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-26664
Alternative links to fulltext:DOI
Abstract
Abstract—Adenylyl cyclases (ACs) are promising pharmacological targets for treating heart failure, cancer, and psychosis. Ribosesubstituted nucleotides have been reported as a potent family of AC inhibitors. In silico analysis of the docked conformers of such nucleotides in AC permits assembly of a consistent, intuitive QSAR model with strong correlation relative to measured pKi values. Energy ...
Owner only: item control page
Download Statistics